Abstract

This study aimed to assess the possible feeding behavior alterations by central interactions of cholecystokinin (CCK) and glutamatergic systems in neonatal chickens. In experiment 1, chickens received intracerebroventricular (ICV) administration of saline and CCK (CCK<sub>4</sub>; 0.25, 0.5, and 1 nmol). In experiment 2, birds were ICV injected with saline, CCK<sub>8s</sub> (0.25, 0.5, and 1 nmol). In experiment 3, chickens received the ICV injection of saline, CCK<sub>8s</sub> (1 nmol), MK-801 (15 nmol), and co-injection of the CCk<sub>8s</sub>+MK-801. Experiments 4-7 were performed similar to experiment 3, except for chickens that were injected with CNQX (390 nmol), AIDA (2 nmol), LY341495 (150 nmol), and UBP1112 (2 nmol) instead of MK-801. Subsequently, the total amount of the consumed food was determined. According to the results, the ICV administration of CCK<sub>4</sub> (0.25, 0.5, and 1 nmol) could not affect the food intake in chickens (<i>P</i>&gt;0.05). The ICV injection of the CCK<sub>8s</sub> (0.25, 0.5, and 1 nmol) led to a dose-dependent hypophagia (<i>P</i>&lt;0.05). Moreover, hypophagia induced by CCK<sub>8s</sub> decreased by the co-injection of the CCK<sub>8s</sub>+MK-801 (<i>P</i>&lt;0.05). These results showed that the hypophagic effects of the CCK on food intake can be mediated by NMDA glutamate receptors in layer-type chickens.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.